BackDaBomb Protein Biotech Overview

DaBomb Protein Biotech Long Term Debt

Latest long-term debt for 6578.TWO: $7.5M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$7.55M
↓ 69.16% YoYΔ $-16.93M vs prior year quarter

Peer trimmed avg / median

Loading

DaBomb Protein Biotech Long Term Debt History

Loading

DaBomb Protein Biotech vs. peers: Long Term Debt Comparison

Loading

DaBomb Protein Biotech Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

DaBomb Protein Biotech (6578.TWO) FAQ

DaBomb Protein Biotech (6578.TWO) currently reports a long-term debt of $7.5M as of September 2026. That compares with $24M in the prior-year period — down 69.2% year over year. Use the charts on this page to explore DaBomb Protein Biotech's long-term debt history and peer comparisons.

DaBomb Protein Biotech's long-term debt decreased from $24M to $7.5M — a 69.2% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

DaBomb Protein Biotech reported $7.5M in long-term debt as of September 2026. That compares with $24M in the prior-year period — down 69.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $7.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DaBomb Protein Biotech, and consider following 6578.TWO for alerts when major investors trade the stock.